Journal
TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 26, Issue 8, Pages 422-429Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2015.05.010
Keywords
-
Categories
Funding
- American Heart Association
- National Institutes of Health [HL128069]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128069] Funding Source: NIH RePORTER
Ask authors/readers for more resources
AMP-activated protein kinase (AMPK) is a critical regulator of cellular metabolism and plays an important role in diabetes, cancer, and vascular disease. In the heart, AMPK activation is an essential component of the adaptive response to cardiomyocyte stress that occurs during myocardial ischemia. During ischemia-reperfusion, AMPK activation modulates glucose and fatty acid metabolism, mitochondrial function, endoplasmic reticulum (ER) stress, autophagy, and apoptosis. Pharmacological activation of AMPK prevents myocardial necrosis and contractile dysfunction during ischemia-reperfusion and potentially represents a cardioprotective strategy for the treatment of myocardial infarction. This review discusses novel mechanisms of AMPK activation in the ischemic heart, the role of endogenous AMPK activation during ischemia, and the potential therapeutic applications for AMPK-directed therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available